373 related articles for article (PubMed ID: 29274889)
1. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.
Ricciuto A; Kamath BM; Walters TD; Frost K; Carman N; Church PC; Ling SC; Griffiths AM
J Pediatr; 2018 Mar; 194():128-135.e1. PubMed ID: 29274889
[TBL] [Abstract][Full Text] [Related]
2. New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease.
Shelton E; Chaudrey K; Sauk J; Khalili H; Masia R; Nguyen DD; Yajnik V; Ananthakrishnan AN
Aliment Pharmacol Ther; 2015 May; 41(10):972-9. PubMed ID: 25756190
[TBL] [Abstract][Full Text] [Related]
3. Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab.
Parisi I; O'Beirne J; Rossi RE; Tsochatzis E; Manousou P; Theocharidou E; Hamilton M; Murray C; Epstein O; Burroughs AK
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):786-91. PubMed ID: 27015138
[TBL] [Abstract][Full Text] [Related]
4. Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
Weizman AV; Sharma R; Afzal NM; Xu W; Walsh S; Stempak JM; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
Dig Dis Sci; 2018 Sep; 63(9):2430-2438. PubMed ID: 29736839
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.
Rodrigues S; Lopes S; Magro F; Cardoso H; Horta e Vale AM; Marques M; Mariz E; Bernardes M; Lopes J; Carneiro F; Macedo G
World J Gastroenterol; 2015 Jun; 21(24):7584-8. PubMed ID: 26140007
[TBL] [Abstract][Full Text] [Related]
6. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
Eickstaedt JB; Killpack L; Tung J; Davis D; Hand JL; Tollefson MM
Pediatr Dermatol; 2017 May; 34(3):253-260. PubMed ID: 28211161
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study.
Koller T; Galambosova M; Filakovska S; Kubincova M; Hlavaty T; Toth J; Krajcovicova A; Payer J
World J Gastroenterol; 2017 Jun; 23(22):4102-4111. PubMed ID: 28652663
[TBL] [Abstract][Full Text] [Related]
9. Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.
Ghabril M; Bonkovsky HL; Kum C; Davern T; Hayashi PH; Kleiner DE; Serrano J; Rochon J; Fontana RJ; Bonacini M;
Clin Gastroenterol Hepatol; 2013 May; 11(5):558-564.e3. PubMed ID: 23333219
[TBL] [Abstract][Full Text] [Related]
10. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease.
Aardoom MA; Veereman G; de Ridder L
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126015
[TBL] [Abstract][Full Text] [Related]
11. Anti-Tumor Necrosis Factor-α-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.
Andrade P; Lopes S; Gaspar R; Nunes A; Magina S; Macedo G
Dig Dis Sci; 2018 Mar; 63(3):746-754. PubMed ID: 29349693
[TBL] [Abstract][Full Text] [Related]
12. Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.
Pastore S; Naviglio S; Canuto A; Lepore L; Martelossi S; Ventura A; Taddio A
Paediatr Drugs; 2018 Apr; 20(2):165-171. PubMed ID: 29214394
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.
Pugliese D; Guidi L; Ferraro PM; Marzo M; Felice C; Celleno L; Landi R; Andrisani G; Pizzolante F; De Vitis I; Papa A; Rapaccini GL; Armuzzi A
Aliment Pharmacol Ther; 2015 Oct; 42(7):880-8. PubMed ID: 26235565
[TBL] [Abstract][Full Text] [Related]
14. Six Cases of Lung Injury Following Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease.
Lee HS; Jo KW; Shim TS; Song JW; Lee HJ; Hwang SW; Park SH; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Kim JH; Yang SK
J Crohns Colitis; 2015 Nov; 9(11):1053-7. PubMed ID: 26221002
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.
Rossi RE; Parisi I; Despott EJ; Burroughs AK; O'Beirne J; Conte D; Hamilton MI; Murray CD
World J Gastroenterol; 2014 Dec; 20(46):17352-9. PubMed ID: 25516646
[TBL] [Abstract][Full Text] [Related]
16. Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease.
Cheon JH
J Gastroenterol Hepatol; 2017 Apr; 32(4):769-777. PubMed ID: 27723166
[TBL] [Abstract][Full Text] [Related]
17. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
Sokolove J; Strand V; Greenberg JD; Curtis JR; Kavanaugh A; Kremer JM; Anofrei A; Reed G; Calabrese L; Hooper M; Baumgartner S; Furst DE;
Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
[TBL] [Abstract][Full Text] [Related]
18. Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study.
Bae JM; Lee HH; Lee BI; Lee KM; Eun SH; Cho ML; Kim JS; Park JM; Cho YS; Lee IS; Kim SW; Choi H; Choi MG
Aliment Pharmacol Ther; 2018 Jul; 48(2):196-205. PubMed ID: 29869804
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Guerra I; Pérez-Jeldres T; Iborra M; Algaba A; Monfort D; Calvet X; Chaparro M; Mañosa M; Hinojosa E; Minguez M; Ortiz de Zarate J; Márquez L; Prieto V; García-Sánchez V; Guardiola J; Rodriguez GE; Martín-Arranz MD; García-Tercero I; Sicilia B; Masedo Á; Lorente R; Rivero M; Fernández-Salazar L; Gutiérrez A; Van Domselaar M; López-SanRomán A; Ber Y; García-Sepulcre M; Ramos L; Bermejo F; Gisbert JP;
Inflamm Bowel Dis; 2016 Apr; 22(4):894-901. PubMed ID: 26933750
[TBL] [Abstract][Full Text] [Related]
20. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review.
Kok B; Lester ELW; Lee WM; Hanje AJ; Stravitz RT; Girgis S; Patel V; Peck JR; Esber C; Karvellas CJ;
Dig Dis Sci; 2018 Jun; 63(6):1654-1666. PubMed ID: 29564668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
